Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer
Clinical trial NCT04489940 · TERMINATED
Trial details
- NCT number
- NCT04489940
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-12
- Primary completion
- 2022-01-27
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.